Abattis Bioceuticals inks $5 mln facility with Alumina Partners
Abattis Bioceuticals Corp has agreed to receive a draw-down equity facility of up to $5 million. The investor is Alumina Partners, a U.S. private equity firm. Abattis, which is based in Vancouver, aggregates, integrates and invests in agricultural technology and biotechnology services for the emerging cannabis industry in Canada. It said it will use the proceeds of the facility to focus on growth opportunities and potential acquisitions.
9 December 2016•4 mins read
